Madras High Court Upholds Appointment of District Judges as Tamil Nadu Lokayukta Secretary  ||  Allahabad High Court: IO’s Mere Apprehension Cannot Justify Withholding Seized Items  ||  Patna High Court: Mere Sight of Spouse in Compromising Position doesn't Prove Adultery  ||  Sikkim High Court: POCSO Case not Quashed on Settlement after Survivor Turns Major  ||  Chhattisgarh High Court: Backward Classes Commission Cannot Decide Private Commercial Disputes  ||  SC: Futures & Options Investors Cannot Recover Trading Losses From Professional Clearing Members  ||  Supreme Court: NCTE Executive Committee Can Seek Annual Reports From Teacher Education Institutes  ||  SC: S.362 CrPC Cannot Limit HC’s Inherent Power to Recall Judgment Causing Miscarriage of Justice  ||  Supreme Court Upholds RBI’s Power to Supersede Multi-State Co-op Bank Boards Beyond Six Months  ||  Supreme Court: Retaining Victim in a Specific Role Cannot Reduce Functional Disability    

National Pharmaceutical Pricing Authority Notifies All Medical Devices Under Price Control - (02 Apr 2020)

LAW OF MEDICINE

National Pharmaceutical Pricing Authority has notified all medical devices sold in India as ‘drugs’ to bring the devices — such as syringes, needles, cardiac stents, a knee implant, digital thermometers, CT scan, MRIs and dialysis machines — under the purview of price control and prohibit firms from hiking their costs by more than 10% annually at a time.

Tags : NATIONAL PHARMACEUTICAL PRICING AUTHORITY   ALL MEDICAL DEVICES UNDER PRICE CONTROL  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved